Observational studyEye (London, England)2025

2-year results from an observational study of proactive treatment regimens with intravitreal aflibercept 2 mg in patients with nAMD in clinical practice: XTEND study UK cohort.

Clare Bailey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.